Home » Topics » BioWorld Science

BioWorld Science
RSS

Opioids impervious to GLP-1 agonists

April 26, 2019

FDA accepts IND for AR-13503 sustained-release implant for wet AMD and DME

April 25, 2019

Emendo Biotherapeutics signs licensing agreement with Takeda Pharmaceutical for OMNI nuclear program

April 25, 2019

Selective and potent RAS inhibitor MCI-062 active against RAS-driven cancers

April 25, 2019

Forge Therapeutics, Basilea Pharmaceutica enter research collaboration to develop novel antibiotics

April 25, 2019

Scancell cleared to begin U.K. arm of SCIB-1 phase II trial in advanced melanoma

April 25, 2019

Haplogen presents new PLA2 inhibitors

April 25, 2019

Enrollment opens in phase I study of IMA-203 TCR-engineered T cells for solid tumors

April 25, 2019

GlaxoSmithKline discloses BRD4 inhibitors

April 25, 2019

Medshine Discovery and collaborator identify adenosine A2A receptor antagonists

April 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...